权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Diversity in the Cancer Care Workforce

癌症护理人员队伍的多样性

基本信息

批准号：
10655717
负责人：
Dowin Boatright
金额：
$ 85.88万
依托单位：
YALE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-06-23 至 2026-12-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10655717
关键词：
Address Affect American Medical Association Area Association of American Medical Colleges Black race Businesses Caring Characteristics Clinical Data Colorectal Cancer Data Data Linkages Data Sources Diagnosis Disparity Early Diagnosis Equity Ethnic Origin General Population Geographic Locations Geography Goals Guidelines Health system Healthcare Market Hematology Individual Knowledge Latinx Latinx population Literature Malignant Neoplasms Malignant neoplasm of lung Malignant neoplasm of prostate Medicare Medicine Methods Oncologist Oncology Outcome Patient Care Patient-Focused Outcomes Patients Patterns of Care Performance Physicians Play Population Provider Public Health Quality of Care Race Research Retrospective Studies Role SEER Program Science Screening for cancer Stage at Diagnosis Structural Racism Training Programs Variant Work cancer care cancer diagnosis cancer health disparity cancer therapy clinical care contextual factors end of life end of life care ethnic disparity ethnic diversity geographic difference improved indexing individual patient malignant breast neoplasm medical specialties neoplasm registry novel novel strategies population based racial disparity racial diversity sociodemographics

项目摘要

Significance: The racial and ethnic distribution of the cancer workforce contrasts starkly with that of the general population. Only 2-3% of oncologists identify as Black or Latinx, compared to 13% and 18% of the U.S. population, respectively. While evidence from the business literature suggests that diversity in teams impacts organizational performance, it is not known whether provider team diversity as well as patient-provider racial and ethnic concordance is associated with quality of cancer-related care and outcomes. If the diversity of teams (physician patient-sharing networks) does indeed improve cancer care, this benefit could improve care for all patients, regardless of the individual patient's race or ethnicity or the race or ethnicity of their provider. Objective: Our over-arching goal is to generate actionable evidence to inform efforts to improve cancer workforce diversity and increase equity in cancer care. Our hypothesis is that the racial and ethnic representation of the oncology workforce varies across regions and patient-sharing networks and that this variation is associated with clinical care. Previously, addressing this knowledge gap has not been possible due to a lack of available data combining physician race and ethnicity with patient clinical data. Specific Aims: We propose a retrospective study using a novel data linkage between the American Medical Association; Association of American Medical Colleges; Surveillance, Epidemiology and End Results population-based cancer registries; and Medicare data to address the following aims: (Aim 1) To ethnic and sharing and regions patient-sharing or assess changes in racial and diversity of the cancer physician and trainee workforce between 2015 and 2020, according to specialty regional healthcare market and ( Aim 1A ) to assess the racial and ethnic diversity of physician patient- networks providing cancer care during the period 2015 – 2020; ( Aim 2 ) To assess variation in racial ethnic representativeness of the oncology workforce across specialty, physician networks, and geographic and (Aim 2A) to identify whether underrepresented in medicine (URM) physicians, as well as physician networks containing a higher proportion of URM physicians, are more likely to care for Black Latinx patients with cancer; ( Aim 3 )To assess geographic and health system contextual factors (e.g. health system factors, area sociodemographics, and structural racism) associated with physician diversity within physician patient-sharing networks; (Aim 4) Among patients diagnosed with invasive lung, prostate, breast, or colorectal cancer during 2015-2019, to networks Receipt assess the association between the racial diversity of their physician , and ( Aim 4A) Early stage at diagnosis for patients with colorectal or breast cancer, ( Aim 4B ) of guideline-concordant cancer treatment, and ( Aim 4C) Quality of end of life care. Through this study, we will create a novel data linkage, and incorporate network science methods to further our understanding of the cancer physician workforce and to identify whether physician team diversity may serve as a previously unidentified mechanism of reducing racial and ethnic disparities in cancer outcomes.

意义：癌症工作人员的种族和民族分布与美国的形成鲜明对比